Dialectic Therapeutics
Dr. Hromas is currently the Dean of the Long School of Medicine at the University of Texas Health Science Center at San Antonio. Previously he was Chair of Medicine at the University of Florida, Deputy Director of Indiana University Cancer Center, and Deputy Director and Chief of Hematology-Oncology at the University of New Mexico Cancer Center. Dr. Hromas has been continuously funded by the NIH in cancer research for almost three decades. He currently serves as Chairman of the SAB of Abfero Pharmaceuticals.
This person is not in the org chart
This person is not in any offices
Dialectic Therapeutics
Dialectic is a Texas-based clinical-stage biotechnology company focused on creating innovative new technologies to treat cancer.